KRAS and neoplasm: Importantly, the prognostic significance of IL12B was further strengthened by its ability to stratify within many currently known prognosticators, including gender (female), age at diagnosis (>65 for OS), tumor stage I, with EGFR mutation, and without KRAS mutation.